Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
In the seminar, Matsson will present examples from his company — in the fields of rheumatoid arthritis, hypersensitivity to gluten and allergies. In the case of hypersensitivity to gluten, he says that their technology can diagnose the disorder with a 95 percent certainty with just one test. This is compared with the average time to diagnose hypersensitivity to gluten in the US which is eleven years. In the context of health economy, Matsson argues that improved and more standardized routines for diagnostics would save a lot of money and also spare patients from unnecessary suffering. In the case of allergies, he argues that a combination of asthma and allergy increases the risk of hospitalization to such an extent that allergy screening is economically defensible. “It is a fascinating development we see in the health care sector today. At the seminar I hope to have a discussion with both medical doctors, politicians and decision makers at hospitals about the possibilities for diagnostics and the health economy.”
